|
Volumn 452, Issue 7187, 2008, Pages 510-511
|
Drug markers questioned
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIARRHYTHMIC AGENT;
BIOLOGICAL MARKER;
CHOLESTEROL;
EZETIMIBE PLUS SIMVASTATIN;
GLUCOSE;
IMATINIB;
ROSIGLITAZONE;
SODIUM CHANNEL BLOCKING AGENT;
BIOMARKER;
CARDIOVASCULAR DISEASE;
DRUG DEVELOPMENT;
RESEARCH WORK;
ARTERY WALL;
ARTICLE;
BLOOD PRESSURE MEASUREMENT;
CHOLESTEROL BLOOD LEVEL;
CLINICAL TRIAL;
DISEASE MARKER;
DRUG APPROVAL;
GLUCOSE BLOOD LEVEL;
HEART DISEASE;
HEART INFARCTION;
HEART PROTECTION;
HUMAN;
HYPERTENSION;
MEDICAL ERROR;
PRIORITY JOURNAL;
STROKE;
|
EID: 41649104305
PISSN: 00280836
EISSN: 14764687
Source Type: Journal
DOI: 10.1038/452510a Document Type: Article |
Times cited : (15)
|
References (6)
|